New Research Released on Hemispherx Biopharma $HEB

Posted by Laura Swartz

November 28, 2016 at 8:51 PM

An Executive Informational Overview (EIO) is now available on specialty pharmaceutical company, Hemispherx Biopharma, Inc. (HEB-NYSE). The EIO is a 60-page report detailing Hemispherx's business, product development, strategic relationships, market opportunities, competition, financials, risks, and more. It is available for download below.

Read More

Topics: HEB

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic